Belapectin (also known as GR-MD-02) is a galectin-3 inhibitor developed by Galectin Therapeutics that is in clinical trials for the treatment of non-alcoholic steatohepatitis.
Owlapps.net - since 2012 - Les chouettes applications du hibou